Table 3 The 3- year local control rate, disease-free survival rate, metastasis-free survival and overall survival rate of cisplatin versus carboplatin according to stage

Stage IIB

Cisplatin (N = 137)

Carboplatin (N = 76)

p-value

Local control

96.7 %

95.3 %

0.68

Disease-free survival

86.8 %

86 %

0.78

Metastasis-free survival

87.9 %

88.4 %

0.98

Overall survival

89 %

93 %

0.5

Stage IIIB

Cisplatin (N = 137)

Carboplatin (N = 76)

p-value

Local control

93.2 %

83.9 %

0.22

Disease-free survival

75 %

71 %

0.88

Metastasis-free survival

77.3 %

83.9 %

0.44

Overall survival

84.1 %

84 %

0.99